4,871 followers
New Research: What do we do now that the long-acting growth hormone is here?: In standard 52-week phase III clinical trials, once weekly lonapegsomatropin, somatrogon and somapacitan have been found to yield non-inferior height… https://t.co/PAvCDYA0WF #En